Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Test source : Www.biospace.com save search
New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
Published: 2024-04-22 (Crawled : 17:00) - biospace.com/
VCYT | News | $19.82 -0.15% -0.15% 560K
|
Health Technology
|
| O: 1.03%
H: 2.65%
C: 1.02%
active test cancer for study
FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
GH | News 4 | $17.34 -1.42% -1.44% 1.8M
|
Health Services
|
| O: 4.42%
H: 5.36%
C: 4.83%
fda test review cancer blood for
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
LH M | $207.97 2.41% 0.0% 930K
|
Health Services
|
| O: 0.82%
H: 0.0%
C: 0.0%
test blood for neurodegenerative labcorp
QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay
Published: 2024-04-10 (Crawled : 12:30) - biospace.com/
QDEL | News 4 | $40.43 3.45% 3.34% 1.2M
|
Health Technology
|
| O: -2.64%
H: 2.3%
C: 1.24%
vitros partnership test assay
Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit
Published: 2024-04-10 (Crawled : 12:00) - biospace.com/
LH M | $207.97 2.41% 0.0% 930K
|
Health Services
|
| O: -0.9%
H: 0.0%
C: 0.0%
fda test authorization for home labcorp
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
Published: 2024-04-08 (Crawled : 00:00) - biospace.com/
EXAS | $63.55 1.83% 1.79% 1.7M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
test sciences meeting study
Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
NTRA | News M | $91.07 2.78% 2.7% 1.1M
|
Health Services
|
| O: 0.92%
H: 0.26%
C: -2.26%
test for heart
Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
Published: 2024-04-02 (Crawled : 15:30) - biospace.com/
DGX | News | $136.7 5.08% 0.0% 2.1M
|
Health Services
|
| O: -0.13%
H: 0.0%
C: -1.72%
test genetic diagnostics
Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -1.38%
fda test rapid blood clearance
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
Published: 2024-03-28 (Crawled : 12:30) - biospace.com/
EXAS | $63.55 1.83% 1.79% 1.7M
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
oncoguard test cancer sciences
Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring
Published: 2024-03-26 (Crawled : 17:00) - biospace.com/
PSNL | $1.385 9.92% 9.03% 180K
|
Health Technology
|
| O: 4.17%
H: 2.0%
C: -4.67%
personal test cancer publication treatment response
Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease
Published: 2024-03-26 (Crawled : 12:00) - biospace.com/
DGX | News | $136.7 5.08% 0.0% 2.1M
|
Health Services
|
| O: 0.26%
H: 0.1%
C: -0.58%
disease test blood alzheimer's imaging study
GRAIL Announces Novel Risk Classification Test to Be Used in Lung Cancer Study
Published: 2024-03-18 (Crawled : 13:30) - biospace.com/
ILMN | $124.41 3.46% 3.34% 1.3M
|
Health Technology
|
| O: 0.51%
H: 2.49%
C: 1.37%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.45%
H: 0.55%
C: -0.24%
lung test cancer risk study
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
Published: 2024-03-14 (Crawled : 12:00) - biospace.com/
ZOM | $0.1313 0.92% 0.08% 5M
|
Miscellaneous
|
| O: -4.89%
H: 2.87%
C: 1.66%
test diagnostic publication research platform
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
GH | News 4 | $17.34 -1.42% -1.44% 1.8M
|
Health Services
|
| O: -0.75%
H: 4.38%
C: 2.7%
test health cancer study
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
EXAS | $63.55 1.83% 1.79% 1.7M
|
Health Technology
|
| O: -0.43%
H: 1.9%
C: 1.06%
cologuard test results study
QuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in Canada
Published: 2024-03-06 (Crawled : 23:00) - biospace.com/
QDEL | News 4 | $40.43 3.45% 3.34% 1.2M
|
Health Technology
|
| O: 0.14%
H: 0.91%
C: -0.3%
quidel test health approval canada
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
Published: 2024-03-04 (Crawled : 16:00) - biospace.com/
QTRX | $16.085 -1.32% -1.34% 410K
|
Health Technology
|
| O: 3.7%
H: 1.64%
C: 0.25%
fda device disease test granted alzheimer’s designation
Veracyte’s Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines
Published: 2024-02-27 (Crawled : 00:00) - biospace.com/
VCYT | News | $19.82 -0.15% -0.15% 560K
|
Health Technology
|
| O: 0.68%
H: 0.34%
C: -0.42%
guidelines test cancer molecular
Curative Insurance Company Adds GRAIL’s Galleri® Test to Member Benefits for Multi-Cancer Early Detection
Published: 2024-02-01 (Crawled : 20:00) - biospace.com/
ILMN | $124.41 3.46% 3.34% 1.3M
|
Health Technology
|
| O: 0.48%
H: 1.56%
C: 1.43%
galleri company test insurance benefits
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.